Vuse has submitted for review to FDA for PMTA, jumping Juul

Reynolds American Inc said on Friday it had filed for a review of its Vuse e-cigarettes by the U.S. Food and Drug administration (FDA), giving it a jump ahead of its main rival Juul Labs.

The FDA has set a May 2020 deadline for e-cigarette makers to submit a formal application to keep their products on the market amid its efforts to curb the use of e-cigarette among teens, according to a story by Reuters.

Reynolds, whose Vuse e-cigarettes deliver nicotine via a cartridge-based vapor system, said it had provided the health regulator with over 150,000 pages of documentation, including information on the composition, design and manufacturing process associated with its product, as well as safety data, according to the story.

The company said it had also worked with a team of more than 100 people to prepare the filing, including multiple regulatory experts and scientists, according to the story.